AUS
NZ
UK
CA
USA
IND
Healt
Dimerix Reports Increased Net Loss for First Half of 2025
February 28, 2025 03:53 PM AEDT| By Team Kalkine MediaHighlights:,Financial Performance:,Dimerix recorded a widened net loss, reflecting an increase compared to the previous reporting period.,Share Movement:,The company's stock experienced a decline over the past week.,Market Developments:,Financial res...
Global Health's Half-Year Results and Insights
February 28, 2025 03:52 PM AEDT| By Team Kalkine MediaHighlights,Global Health's revenue increased by 7.3% over the previous year.,The company narrowed its net losses by 39% compared to last year.,Stock prices saw a decline of 13% over the past week.,Global Health (ASX:GLH) recently unveiled its financi...
Universal Biosensors Full Year 2024 Earnings Report: A loss of AU$0.053 per share, compared to a loss of AU$0.032 per share in FY 2023.
February 28, 2025 03:51 PM AEDT| By Team Kalkine MediaHighlights,Revenue decreased by 5.3% from the previous financial year.,Net loss expanded to AU$14.2 million.,Shares have declined by 7.7% over the past week.,Universal Biosensors (ASX:UBI) has reported its full-year financial results for 2024, reveal...
Before Purchasing Sonic Healthcare Limited (ASX:SHL) for Its Upcoming Dividend, Consider These Important Checks
February 28, 2025 03:48 PM AEDT| By Team Kalkine MediaHighlights,Sonic Healthcare’s upcoming ex-dividend date is approaching.,A dividend has been declared at a value per share.,Dividend payout levels highlight sustainability considerations.,Sonic Healthcare (ASX:SHL) operates within the healthcare secto...
Sonic Healthcare's (ASX:SHL) Upcoming Dividend: Key Factors to Consider
February 28, 2025 01:00 PM AEDT| By Team Kalkine MediaHighlights,Ex-dividend date approaching:,Investors need to be aware of the March 5 deadline to be eligible for the next dividend.,Dividend sustainability concerns:,High payout ratio raises questions about long-term dividend stability.,Earnings growth...
ECS Botanics (ASX:ECS) Eyes Global Expansion Amid Revenue Decline and Industry Shifts
February 28, 2025 11:39 AM AEDT| By Team Kalkine MediaHighlights,Revenue declined by 16% due to increased competition and regulatory shifts.,Expansion into export markets, product innovation, and cost reductions drive future potential.,Leadership restructuring aims to enhance operational efficiency.,ECS...
ASX Healthcare Sector Faces Challenges Amidst Volatility
February 28, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,The ASX healthcare sector experienced one of its worst reporting seasons, with over 50% of companies showing negative stock reactions.,Ramsay Health Care (ASX:RHC) saw a notable 8% share price increase due to strong performance in Australi...
Biotech Developments: Key Approvals and Market Prospects
February 28, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Telix Pharmaceuticals expands into Brazil with Illuccix approval, tapping into a large prostate cancer market.,Orthocell secures approval in Singapore for Striate, boosting access in the ASEAN market.,Neurizon Therapeutics set to resume AL...
Institutional Ownership in Australian Clinical Labs Limited (ASX:ACL)
February 27, 2025 04:26 PM AEDT| By Team Kalkine MediaHighlights,Institutional investors hold a significant stake in Australian Clinical Labs, shaping its strategic direction.,The largest shareholders include a mix of institutions, hedge funds, and company insiders.,The general public also holds a subst...
EZZ Life Science Holdings: Financial Performance and Leadership Insight
February 27, 2025 01:39 PM AEDT| By Team Kalkine MediaHighlights:,Earnings per share for EZZ Life Science Holdings has shown consistent growth.,Company leadership holds a significant portion of shares, reinforcing confidence.,CEO's remuneration remains aligned with financial performance and company dire...
Ownership Structure of Integral Diagnostics and Its Market Influence
February 27, 2025 01:37 PM AEDT| By Team Kalkine MediaHighlights:,Individual investors control the largest portion of Integral Diagnostics' shares.,Institutional ownership reflects significant interest in the company.,Private companies and insiders hold smaller stakes in the business.,Integral Diagnosti...
Should You Be Concerned About CleanSpace Holdings' (ASX:CSX) Debt Despite the Lack of Earnings?
February 27, 2025 01:32 PM AEDT| By Team Kalkine MediaHighlights:,CleanSpace Holdings maintains more liquid assets than liabilities, with a strong cash position.,The company reports steady revenue growth, reflecting an expanding market presence.,A net cash balance underscores financial stability, reduci...
Investors who put their money into Genetic Signatures (ASX:GSS) three years ago are still facing a 51% loss, despite seeing a 16% increase over the past week.
February 27, 2025 01:31 PM AEDT| By Team Kalkine MediaHighlights:,The stock price of Genetic Signatures Limited has experienced an upward movement this week.,Over the past several years, revenue has shown a downward trend, impacting overall stock performance.,Recent share acquisitions by company insider...
Neuren Pharmaceuticals Reports Record Sales Growth for Rett Syndrome Drug
February 27, 2025 12:21 PM AEDT| By Team Kalkine MediaHighlights,Neuren,Pharmaceuticals (NEU) sees a 97% surge in full-year sales for Rett syndrome drug DAYBUE™.,Acadia Pharmaceuticals (,NASDAQ:ACAD,) reports record quarterly and full-year sales in the US.,Forecasted royalties for,Neuren,Pharmaceuticals...
Monash IVF Group (ASX:MVF) Delivers Strong Performance with Double-Digit Revenue Growth in 1H25
February 27, 2025 12:09 PM AEDT| By Team Kalkine MediaHighlights,Revenue surged 11.6% to $140.3 million in the first half of 2025.,Underlying,NPAT increased by 5.5% to $15.8 million,Expanding fertility services with new specialists and infrastructure projects.,Monash IVF Group (ASX:MVF) has reported a s...
AnteoTech's impressive performance in the first half of FY2025 paves the way for future growth.
February 27, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,AnteoTech reports a 74% increase in revenue driven by strategic commercial initiatives.,Significant progress noted in Clean Energy and Life Sciences sectors, with key partnerships enhancing growth.,The company's financial strategies includ...
Neuren Shares See Half-Price Discount as Brokers Sound the Alarm
February 27, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Neuren Pharmaceuticals (ASX:NEU) sees potential leveraged growth for its Rett syndrome drug, Daybue.,February's biotech sector downturn offers opportunities for investment research as major stocks face price corrections.,Dimerix (ASX:DXB)...
What's Happening with Actinogen’s Xanamem in 2025?
February 27, 2025 10:30 AM AEDT| By Team Kalkine MediaHighlights,The biotechnology sector is driving advancements in neurological disorder treatments, with a focus on Alzheimer’s disease.,Actinogen Medical has received an international non-proprietary name for Xanamem, marking a key regulatory milestone...
Nanosonics Limited Reports Strong Earnings and Cash Flow Performance
February 26, 2025 07:31 PM AEDT| By Team Kalkine MediaHighlights:,Nanosonics Limited demonstrates strong earnings growth in its latest financial update.,The company’s free cash flow surpasses reported profits, reflecting efficient cash management.,Earnings per share have shown significant improvement ov...
If the Liberals secure victory in the WA election, anticipate significant changes in the mining sector, beginning with a substantial reduction in red tape.
February 26, 2025 04:31 PM AEDT| By Team Kalkine MediaHighlights,Political debates intensify over mining policies ahead of WA elections.,Proposed reforms could impact regulations, land access, and labor markets.,Industry stakeholders watch closely as policies evolve.,The mining and resources sector is a...
Advertise your brand on Kalkine Media